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Introduction
Human T-cell lymphotropic virus 1 and 2 (HTLV-1, HTLV-2)
belong to the Retroviridae family, genus Deltaretrovirus1,2 and
have similar biological properties, with tropism of T lym-
phocytes. They are associated with rare lymphoproliferative
diseases.3,4
Brazil has a high seroprevalence of HTLV-1/2 among blood
donors. The mean prevalence ranges from 0.4/1000 in Flori-
anópolis to 10.0/1000 in São Luís do Maranhão.5
The ﬁrst case of HTLV-2 was described in 1982 in a patient
with hairy cell leukemia.6 The virus is acquired through
unprotected sexual intercourse, by vertical transmission and,
in Europe and North America, infection is associated with
intravenous drug users. HTLV-2 is endemic in some Indian vil-
lages and urban populations in northern Brazil,7 in the state
8of São Paulo and in the central western region of the country.
HTLV-2 can be classiﬁed into four major subtypes:
HTLV-2a, HTLV-2b, HTLV-2c and HTLV-2d by molecular
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reserved.characterization.9 Although HTLV-2 does not show any def-
inite association with lymphoproliferative diseases, some
studies have suggested that it may also be associated with
HTLV-I-associated Myelopathy/Tropical Spastic Paraparesis
(HAM/TSP) and other neurological syndromes, as well as
increased incidence of pneumonia, bronchitis and inﬂamma-
tory conditions and arthritis.10
These case reports show the occurrence of HTLV-2 in blood
donors of the state of Maranhão for the ﬁrst time, thus indi-
cating the need for work on this issue in the region to discover
the real prevalence of the virus.
Case  report
Two patients were referred to the clinic specializing in HTLV-
1/2 at the Supervisão de Hematologia e Hemoterapia doPrac¸a Madre Deus 1, Madre Deus, São Luís, MA, Brazil.
Maranhão (HEMOMA). Both women were married housewives
living in São Luís do Maranhão with only elementary school-
ing. One was 54 years old and the other was 61 years old. They
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onated blood for family members but the screening labora-
ory test (ELISA) was positive for HTLV-1/2. This result was
onﬁrmed for HTLV-2 by Western blot. The patients denied
aving a family history of HTLV, blood transfusions or infec-
ious dermatitis during childhood. Their partners refused to
erform blood tests. The patients’ physical examinations and
aboratory analyses, including complete blood count, urea,
reatinine, fasting glucose, uric acid, lipid proﬁle, TSH, T3 and
ree T4, were unremarkable.
iscussion
TLV-1/2 infection is endemic in Brazil11 with a prevalence of
% of the population. There is a high incidence in Maranhão,
here ten out of every 1000 blood donors are seropositive.12
owever, these ﬁgures do not show the real situation in
he population of Maranhão as they are for blood donors
nd not the general public. A study conducted in São Paulo
ound a rate of 20.7% for HTLV-2a/b13 and a rate of 0.24% for
TLV-2a/c was found in a population of the central-western
egion of Brazil in patients co-infected with pulmonary
uberculosis.8
In regions where HTLV-2 infection is endemic, the high-
st prevalence is associated with increased age and decreased
ocioeconomic status, especially in women,14 which corrobo-
ates our ﬁndings.
The pathogenic inferiority of HTLV-2 compared to HTLV-
15 is known and so it is not clearly associated with diseases,
lthough there are reports of an association of HTLV-2 with
eurological diseases and increased incidence of respiratory
nfections16; this explains the absence of symptoms reported
n these patients.
onclusion
hese case reports will contribute to the planning and
mplementation of control measures by the epidemiological
urveillance agency of Maranhão. Thus, despite of the small
ample size in blood donors, this seropositivity indicates the
eed of further studies in the whole population of the state of
aranhão.
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